Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.10.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 09, 2018
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q3  
Entity Registrant Name EYEGATE PHARMACEUTICALS INC  
Entity Central Index Key 0001372514  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Trading Symbol EYEG  
Entity Common Stock, Shares Outstanding   43,443,878
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Small Business true